IPO - Biodexa Pharmaceuticals Plc

Form Type: CORRESP

Filing Date: 2025-01-23

Corporate Action: Ipo

Type: New

Accession Number: 000121465925001211

Filing Summary: Biodexa Pharmaceuticals PLC requests the acceleration of the effective date for its Registration Statement on Form F-1 (File No. 333-284350) to 4:30 PM Eastern Time on January 27, 2025, or as soon as practicable thereafter. The company seeks confirmation of this effectiveness by contacting Jason S. McCaffrey, their legal counsel. The request is made under Rule 461 of the General Rules and Regulations of the Securities Act of 1933.

Document Link: View Document